Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Investigating the cause of racial/ethnic disparity in pancreatic cancer incidence
HIV-1 Tat genetic variation impacts NeuroAIDS
Towards identification of prognostic gene sets in breast cancer: The E2197 Trial
Cation and Ligand Binding to Unusual DNA Structures
Biochemical Mechanisms of an Rb-Associated SP1 Inhibitor
Recently added grants:
De-implementation of low value castration for men with prostate cancer
Metabolic and Genetic Heterogeneity in Cancer
Coordinate Regulation of Oncogenic Signaling Pathways in SPOP Mutant Prostate Cancer
Integrin alpha6beta4 regulation of cancer epigenetics
Mechanisms of enhancer regulation in leukemia
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research and Development Contracts (N01)
Project #
N01HB67185-2-0-1
Application #
7574879
Study Section
Project Start
2006-09-30
Project End
2009-12-31
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 HL
Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension
/ University of Colorado Denver
$385,356
NIH 2007
N01 HL
Sildenafil for Sickle Cell Disease-Associated Pulmonary Hypertension
Badesch, David /
$360,397
NIH 2007
N01 HL
Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension
/
Comments
Be the first to comment on this grant